Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma
Authors:
- Steven B. NewmanSNSteven B. Newman
- Tom R. DeMeesterTDTom R. DeMeester
- Harvey M. GolombHGHarvey M. Golomb
- Philip C. HoffmanPHPhilip C. Hoffman
- Alex G. LittleALAlex G. Little
- Vathsala RaghavanVRVathsala Raghavan
- 1 August 1983
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 86 (2) , 180-185
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Survival of patients surgically treated for Stage I lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1981
- Sequential Staging in Bronchogenic CarcinomaChest, 1979
- Metastatic Non-Oat-Cell Bronchogenic Carcinoma1978
- Assessment of the Role of Surgery for Control of Lung CancerThe Annals of Thoracic Surgery, 1977
- Carcinoma of the Lung: Results of Treatment over Ten YearsThe Annals of Thoracic Surgery, 1976
- Surgical therapy of lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1976
- Relationship of Cell Type and Lymph Node Metastasis to Survival After Resection of Bronchial CarcinomaThe Annals of Thoracic Surgery, 1975
- The Effect of Histological Cell Type on the Prognosis of Patients with Bronchogenic CarcinomaThe Annals of Thoracic Surgery, 1972
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965